Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Meghna A Singhania
    Meghna A Singhania

      Meghna A Singhania is the founder and Editor-in-Chief at Medical Dialogues. An Economics graduate from Delhi University and a post graduate from London School of Economics and Political Science, her key research interest lies in health economics, and policy making in health and medical sector in the country. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751

      • Home
      • Meghna A Singhania

      Articles By : Meghna A Singhania

      Stents under Price Control; Government amends Act

      Stents under Price Control; Government amends Act

      Meghna A Singhania22 Dec 2016 12:41 PM IST
      New Delhi: Stents prices will soon have a maximum limit, as the government is moving ahead in its endeavour to bring them under the national list of...
      No Rinse eyes $2 mln revenue from India by March 2017

      No Rinse eyes $2 mln revenue from India by March 2017

      Meghna A Singhania6 Dec 2016 11:26 AM IST
      Mumbai : US-based water less bathing brand No Rinse, which entered India earlier this year, is eyeing a turnover of USD 2 million by March...
      Narayan Seshadri elected AstraZeneca Pharma India Chairman

      Narayan Seshadri elected AstraZeneca Pharma India Chairman

      Meghna A Singhania5 Dec 2016 1:18 PM IST
      New Delhi : Drug firm AstraZeneca Pharma India has said its board has elected independent director, Narayan K Seshadri, as chairman of the...
      EU health regulator warns some hep C drugs could reactivate hep B

      EU health regulator warns some hep C drugs could reactivate hep B

      Meghna A Singhania5 Dec 2016 1:17 PM IST
      The European Medicines Agency warned that some of the most successful hepatitis C treatments on the market could reactivate hepatitis B in patients,...
      Health Care at Home partners with Critinext to enhance ICU at home services

      Health Care at Home partners with Critinext to enhance ICU at home services

      Meghna A Singhania5 Dec 2016 1:17 PM IST
      New Delhi : Home healthcare services provider Health Care at Home (HCAH) has partnered with e-ICU network Critinext to enhance ICU at home services...
      Zydus can launch ulcer drug in US, patent litigation settled

      Zydus can launch ulcer drug in US, patent litigation settled

      Meghna A Singhania5 Dec 2016 1:16 PM IST
      New Delhi : Zydus Cadila, an innovation-driven global pharmaceutical company, announced that the patent litigation relating to Allergan's DELZICOL...
      Big Relief to Pharma Companies: Delhi HC quashes ban on FDC drugs

      Big Relief to Pharma Companies: Delhi HC quashes ban on FDC drugs

      Meghna A Singhania1 Dec 2016 2:08 PM IST
      New Delhi: In a move that would bring great relief to pharmaceutical companies across the country, the Delhi High Court has set aside the government...
      100 percent Protection of Dettol leads to Court Battle

      100 percent Protection of Dettol leads to Court Battle

      Meghna A Singhania30 Sept 2016 4:55 PM IST
      Reckitt Benckiser drags Advertising Standard Council Of India to Court against its recommendation opposing 100% germ protection Jargon New Delhi: One...
      Sun pharma MRs call it a strike on 26th September

      Sun pharma MRs call it a strike on 26th September

      Meghna A Singhania12 Sept 2016 12:37 PM IST
      New Delhi : Around 500 Ex-workers of Ranbaxy, who are now working associted with the pharma giant Sun Pharma, have announced for a pan- India strike...
      Govt mulls ban on OTC fairness creams

      Govt mulls ban on OTC fairness creams

      Meghna A Singhania16 Aug 2016 4:26 PM IST
      New Delhi: Based on the recommendations of many a health professionals, the central government is now mulling over a ban of OTC sales of fairness...
      SC tells CIPLA to deposit Rs 175 crore in overcharging case

      SC tells CIPLA to deposit Rs 175 crore in overcharging case

      Meghna A Singhania23 July 2016 11:31 AM IST
      Mumbai: The Apex court has directed pharmaceutical giant CIPLA to deposit a sum of Rs 175.07 crore with the government in respect to a case of alleged...
      Withdraw Medrol 6 months before expiry: HC to Pfizer

      Withdraw Medrol 6 months before expiry: HC to Pfizer

      Meghna A Singhania22 May 2016 3:48 PM IST
      The Delhi High Court has asked pharma major Pfizer Ltd to withdraw stocks of its already imported drug Medrol, used to treat a wide range of...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok